癌症免疫治疗的兴起为抗癌战役注入了全新活力，其中免疫检查点抑制剂（checkpoint inhibitors, ...

Instead they end in a conserved stem–loop that interacts with stem–loop binding protein (SLBP), a factor involved in several steps of histone mRNA metabolism: pre-mRNA processing, translation ...

This paper advances an important new concept in psoriasis pathogenesis and implicates Sema4a as a homeostatic regulator that is highly epithelial-specific. The findings are convincing and lend support ...

Russia’s mRNA vaccine targets cancer using AI-powered personalisation Free distribution for Russian citizens begins in 2025 The vaccine trains the immune system to fight cancer effectively ...

The technology-driven Nasdaq-100 has delivered an impressive performance in 2024, posting a nearly 30% return year-to-date. This strong showing has been propelled by a few standout stocks, while ...

Consistent with the ability of selective TLR8 inhibitor to block plasma-mediated neutrophil activation, TLR8 agonists, but not TLR7 agonists induced robust neutrophil activation. Further, neutrophil ...

Kawan Renergy Berhad (KLSE:KENERGY) has had a great run on the share market with its stock up by a significant 33% over the last month. Since the market usually pay for a company’s long-term ...

In a major medical breakthrough, Russia has unveiled the development of an mRNA-based vaccine aimed at treating cancer. According to reports by the state-run media outlets, the vaccine will be ...

Russia announces the development of an mRNA cancer vaccine, slated for a 2025 launch. Pre-clinical trials demonstrate tumor suppression and metastasis reduction. AI integration promises to ...

Russia announced that it had developed an mRNA vaccine for cancer patients. The vaccine will be available from early 2025 and will be distributed for free. The vaccine will cost the Russian government ...